DBV Technologies (DBVT) Inventory Average (2019)
DBV Technologies (DBVT) posted quarterly Inventory Average of $2.3 million for Q4 2019, up 12.94% on a QoQ basis from $2.1 million in Q2 2019.
DBV Technologies (DBVT) Inventory Average (2019) Analysis & Trends
DBV Technologies (DBVT) has reported Inventory Average for 1 consecutive years, with $2.3 million the latest figure, recorded in Q4 2019.
- Quarterly Inventory Average changed N/A year-over-year to $2.3 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $2.3 million (changed N/A YoY) and the FY2019 annual result came in at $2.0 million, changed N/A from the prior year.
- Inventory Average advanced to $2.3 million in Q4 2019 per DBVT's latest filing, from $2.1 million in the prior quarter.
- Over the last five years, Inventory Average for DBVT reached as high as $2.3 million in Q4 2019 and fell as low as $2.1 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 2.34 Mn |
| Jun 30, 2019 | 2.08 Mn |